David Young, Chief Scientific Officer at QUESTCOR PHARMACEUTICALS INC (QCOR), sold 39,794 shares at $78.88 ($1.8M) on 2014-02-24, disclosed to the SEC on 2014-02-26.
Scheduled sale ($1.8M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 16,667 | $0 | 0.0% |
| 2 | $78.88 | 6,000 | $473K | 25.8% |
| 3 | $79.46 | 17,127 | $1.4M | 74.2% |
| Total | $46.09 avg | 39,794 | $1.8M | 100% |
| Filing → |
| PCSA | BUY | 2026-06-01 | $5K | — | Filing → |
| PCSA | BUY | 2026-05-19 | $5K | — | Filing → |
| PCSA | BUY | 2026-05-01 | $5K | — | Filing → |